• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在雄激素剥夺条件下,去势抵抗性前列腺癌中持续的雄激素受体介导的转录。

Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions.

机构信息

Department of Medicine, Center for Pharmacogenomics, Washington University School of Medicine, St. Louis, MO 63110, USA.

出版信息

Nucleic Acids Res. 2012 Nov;40(21):10765-79. doi: 10.1093/nar/gks888. Epub 2012 Sep 27.

DOI:10.1093/nar/gks888
PMID:23019221
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3510497/
Abstract

The androgen receptor (AR) is a ligand-inducible transcription factor that mediates androgen action in target tissues. Upon ligand binding, the AR binds to thousands of genomic loci and activates a cell-type specific gene program. Prostate cancer growth and progression depend on androgen-induced AR signaling. Treatment of advanced prostate cancer through medical or surgical castration leads to initial response and durable remission, but resistance inevitably develops. In castration-resistant prostate cancer (CRPC), AR activity remains critical for tumor growth despite androgen deprivation. Although previous studies have focused on ligand-dependent AR signaling, in this study we explore AR function under the androgen-deprived conditions characteristic of CRPC. Our data demonstrate that AR persistently occupies a distinct set of genomic loci after androgen deprivation in CRPC. These androgen-independent AR occupied regions have constitutively open chromatin structures that lack the canonical androgen response element and are independent of FoxA1, a transcription factor involved in ligand-dependent AR targeting. Many AR binding events occur at proximal promoters, which can act as enhancers to augment transcriptional activities of other promoters through DNA looping. We further show that androgen-independent AR binding directs a gene expression program in CRPC, which is necessary for the growth of CRPC after androgen withdrawal.

摘要

雄激素受体 (AR) 是一种配体诱导的转录因子,可介导雄激素在靶组织中的作用。配体结合后,AR 结合到数千个基因组位置并激活细胞类型特异性基因程序。前列腺癌的生长和进展依赖于雄激素诱导的 AR 信号。通过医学或手术去势治疗晚期前列腺癌可导致初始反应和持久缓解,但不可避免地会产生耐药性。在去势抵抗性前列腺癌 (CRPC) 中,尽管雄激素剥夺,AR 活性仍然对肿瘤生长至关重要。尽管先前的研究集中在配体依赖性 AR 信号上,但在这项研究中,我们探讨了 CRPC 中雄激素剥夺条件下 AR 的功能。我们的数据表明,在 CRPC 中雄激素剥夺后,AR 持续占据一组独特的基因组位置。这些雄激素非依赖性 AR 占据的区域具有组成型开放的染色质结构,缺乏经典的雄激素反应元件,并且不依赖于 FoxA1,FoxA1 是一种参与配体依赖性 AR 靶向的转录因子。许多 AR 结合事件发生在近端启动子,这些启动子可以作为增强子,通过 DNA 环化增强其他启动子的转录活性。我们进一步表明,雄激素非依赖性 AR 结合指导 CRPC 中的基因表达程序,这是雄激素撤退后 CRPC 生长所必需的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d1/3510497/802e45190cbf/gks888f7p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d1/3510497/4ab86937d9a0/gks888f1p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d1/3510497/2605fdd59ea3/gks888f2p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d1/3510497/23bb6c8b3f99/gks888f3p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d1/3510497/cf7ce5102562/gks888f4p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d1/3510497/f8ee929d5296/gks888f5p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d1/3510497/1a76984e87f5/gks888f6p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d1/3510497/802e45190cbf/gks888f7p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d1/3510497/4ab86937d9a0/gks888f1p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d1/3510497/2605fdd59ea3/gks888f2p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d1/3510497/23bb6c8b3f99/gks888f3p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d1/3510497/cf7ce5102562/gks888f4p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d1/3510497/f8ee929d5296/gks888f5p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d1/3510497/1a76984e87f5/gks888f6p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d1/3510497/802e45190cbf/gks888f7p.jpg

相似文献

1
Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions.在雄激素剥夺条件下,去势抵抗性前列腺癌中持续的雄激素受体介导的转录。
Nucleic Acids Res. 2012 Nov;40(21):10765-79. doi: 10.1093/nar/gks888. Epub 2012 Sep 27.
2
Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer.配体依赖性全长雄激素受体及其剪接变体在去势抵抗性前列腺癌中介导的独特转录程序。
Cancer Res. 2012 Jul 15;72(14):3457-62. doi: 10.1158/0008-5472.CAN-11-3892. Epub 2012 Jun 18.
3
Vav3 enhances androgen receptor splice variant activity and is critical for castration-resistant prostate cancer growth and survival.Vav3增强雄激素受体剪接变体活性,对去势抵抗性前列腺癌的生长和存活至关重要。
Mol Endocrinol. 2012 Dec;26(12):1967-79. doi: 10.1210/me.2012-1165. Epub 2012 Sep 28.
4
Testosterone boosts for treatment of castration resistant prostate cancer: an experimental implementation of intermittent androgen deprivation.睾酮提升治疗去势抵抗性前列腺癌:间歇性雄激素剥夺的实验实施。
Prostate. 2013 Nov;73(15):1699-709. doi: 10.1002/pros.22711. Epub 2013 Jul 19.
5
Angiogenin mediates androgen-stimulated prostate cancer growth and enables castration resistance.血管生成素介导雄激素刺激的前列腺癌生长并使其产生抗阉割作用。
Mol Cancer Res. 2013 Oct;11(10):1203-14. doi: 10.1158/1541-7786.MCR-13-0072. Epub 2013 Jul 12.
6
Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.Nrdp1 通过雄激素受体调节雄激素依赖性但非去势抵抗性前列腺癌细胞中 ErbB3 的表达。
Cancer Res. 2010 Jul 15;70(14):5994-6003. doi: 10.1158/0008-5472.CAN-09-4440. Epub 2010 Jun 29.
7
TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer.TACC2是一种雄激素反应性细胞周期调节因子,可促进雄激素介导的前列腺癌生长及去势抵抗性生长。
Mol Endocrinol. 2012 May;26(5):748-61. doi: 10.1210/me.2011-1242. Epub 2012 Mar 28.
8
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells.刺猬/ Gli 支持去势和去势抵抗性前列腺癌细胞中的雄激素信号。
Mol Cancer. 2010 Apr 26;9:89. doi: 10.1186/1476-4598-9-89.
9
Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth.类固醇生成酶 AKR1C3 是一种新型的雄激素受体选择性共激活剂,可促进前列腺癌生长。
Clin Cancer Res. 2013 Oct 15;19(20):5613-25. doi: 10.1158/1078-0432.CCR-13-1151. Epub 2013 Aug 30.
10
Peroxisome proliferator-activated receptor gamma coactivator-1alpha interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR.过氧化物酶体增殖物激活受体γ辅激活因子-1α与雄激素受体(AR)相互作用,并通过激活AR促进前列腺癌细胞生长。
Mol Endocrinol. 2010 Jan;24(1):114-27. doi: 10.1210/me.2009-0302. Epub 2009 Nov 2.

引用本文的文献

1
ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysis.新型雄激素受体靶点ECD通过调节糖酵解促进前列腺癌肿瘤发生。
Oncogene. 2025 Sep 4. doi: 10.1038/s41388-025-03559-x.
2
NASP implication in the androgen receptor associated with castration resistance in prostate cancer.核仁酸性磷酸蛋白在前列腺癌去势抵抗相关雄激素受体中的作用
Cell Commun Signal. 2025 Jul 10;23(1):331. doi: 10.1186/s12964-025-02339-0.
3
Matrix stiffness modulates androgen response genes and chromatin state in prostate cancer.

本文引用的文献

1
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.外显子组测序鉴定前列腺癌中 SPOP、FOXA1 和 MED12 的高频突变。
Nat Genet. 2012 May 20;44(6):685-9. doi: 10.1038/ng.2279.
2
Characterization of genome-wide enhancer-promoter interactions reveals co-expression of interacting genes and modes of higher order chromatin organization.全基因组增强子-启动子相互作用的特征分析揭示了相互作用基因的共表达和更高阶染色质组织的模式。
Cell Res. 2012 Mar;22(3):490-503. doi: 10.1038/cr.2012.15. Epub 2012 Jan 24.
3
Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation.
基质硬度调节前列腺癌中的雄激素反应基因和染色质状态。
NAR Cancer. 2025 Mar 20;7(1):zcaf010. doi: 10.1093/narcan/zcaf010. eCollection 2025 Mar.
4
To eat or not to eat: a critical review on the role of autophagy in prostate carcinogenesis and prostate cancer therapeutics.吃还是不吃:关于自噬在前列腺癌发生和前列腺癌治疗中作用的批判性综述。
Front Pharmacol. 2024 Jun 7;15:1419806. doi: 10.3389/fphar.2024.1419806. eCollection 2024.
5
DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2.DPYSL5 在治疗诱导的神经内分泌前列腺癌中高度表达,并通过 EZH2/PRC2 促进谱系可塑性。
Commun Biol. 2024 Jan 18;7(1):108. doi: 10.1038/s42003-023-05741-x.
6
Transposable Elements Are Co-opted as Oncogenic Regulatory Elements by Lineage-Specific Transcription Factors in Prostate Cancer.转座元件通过前列腺癌中特定谱系转录因子被选为致癌调节元件。
Cancer Discov. 2023 Nov 1;13(11):2470-2487. doi: 10.1158/2159-8290.CD-23-0331.
7
TRAF4-mediated nonproteolytic ubiquitination of androgen receptor promotes castration-resistant prostate cancer.TRAF4 介导的雄激素受体非蛋白水解泛素化促进去势抵抗性前列腺癌。
Proc Natl Acad Sci U S A. 2023 May 16;120(20):e2218229120. doi: 10.1073/pnas.2218229120. Epub 2023 May 8.
8
Up-regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapy.在手术后和激素治疗后,人样本中分泌白细胞蛋白酶抑制剂的上调可能具有预测前列腺癌复发和进展的潜在作用。
Cancer Med. 2023 Feb;12(3):3328-3342. doi: 10.1002/cam4.5134. Epub 2022 Aug 13.
9
Adaptive and non-adaptive gene expression responses in prostate cancer during androgen deprivation.雄激素剥夺治疗期间前列腺癌中的适应性和非适应性基因表达反应
PLoS One. 2023 Feb 21;18(2):e0281645. doi: 10.1371/journal.pone.0281645. eCollection 2023.
10
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer.CRISPR 筛选揭示了前列腺癌中 PARP 抑制剂敏感性和耐药性的遗传决定因素。
Nat Commun. 2023 Jan 17;14(1):252. doi: 10.1038/s41467-023-35880-y.
广泛的启动子为中心的染色质相互作用为转录调控提供了拓扑基础。
Cell. 2012 Jan 20;148(1-2):84-98. doi: 10.1016/j.cell.2011.12.014.
4
Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone.醋酸阿比特龙对骨骼中去势抵抗性前列腺癌雄激素信号的影响。
J Clin Oncol. 2012 Feb 20;30(6):637-43. doi: 10.1200/JCO.2010.33.7675. Epub 2011 Dec 19.
5
Cooperation between Polycomb and androgen receptor during oncogenic transformation.多梳抑制复合物和雄激素受体在致癌转化过程中的合作。
Genome Res. 2012 Feb;22(2):322-31. doi: 10.1101/gr.131508.111. Epub 2011 Dec 16.
6
GeneSigDB: a manually curated database and resource for analysis of gene expression signatures.GeneSigDB:一个手动整理的数据库和资源,用于分析基因表达特征。
Nucleic Acids Res. 2012 Jan;40(Database issue):D1060-6. doi: 10.1093/nar/gkr901. Epub 2011 Nov 21.
7
Detecting differential binding of transcription factors with ChIP-seq.检测转录因子的 ChIP-seq 差异结合。
Bioinformatics. 2012 Jan 1;28(1):121-2. doi: 10.1093/bioinformatics/btr605. Epub 2011 Nov 3.
8
Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer.FoxA1 在雄激素受体与染色质结合、雄激素信号传导和前列腺癌中的双重作用。
EMBO J. 2011 Sep 13;30(19):3962-76. doi: 10.1038/emboj.2011.328.
9
Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer.雄激素受体的过度表达增强了前列腺癌细胞中受体与染色质的结合。
Oncogene. 2012 Apr 26;31(17):2153-63. doi: 10.1038/onc.2011.401. Epub 2011 Sep 12.
10
Post-translational modification of the androgen receptor.雄激素受体的翻译后修饰。
Mol Cell Endocrinol. 2012 Apr 16;352(1-2):70-8. doi: 10.1016/j.mce.2011.07.004. Epub 2011 Jul 24.